Patients with arthritis or ulcerative colitis who have taken Xeljanz or Xeljanz XR may be at increased risk for developing a pulmonary embolism (PE) or deep vein thrombosis (DVT). Lawyers are currently reviewing claims from people who have experienced these injuries and assisting them with filing Xeljanz lawsuits against Pfizer Inc., the manufacturer of the drug.
Our lawyers are currently reviewing claims from people who developed a PE and/or DVT after using Xeljanz or Xeljanz XR for inclusion in the Xeljanz lawsuit against Pfizer Inc., the manufacturer of the drugs.
Blood flows from the heart to the lungs through the pulmonary artery. In the lungs, it is enriched with oxygen, and it then flows back to your heart and then out to the rest of your body.
When a blood clot gets caught in a pulmonary artery, it is called a pulmonary embolism. The clot blocks normal blood flow to the lungs.
A pulmonary embolism is a medical emergency. The lack of oxygen due to the pulmonary embolism can:
The symptoms of a pulmonary embolism may come on suddenly. You should call 911 if you have any of these symptoms:
It is also possible to have a pulmonary embolism and no warning symptoms.
When a blood clot forms in a deep vein, it is called deep vein thrombosis. Usually such clots develop in the leg; sometimes they occur in the arm or other deep veins. If such a clot or clots break off and travel to your lung, it becomes a pulmonary embolism.
Symptoms of deep vein thrombosis include:
If you or a loved one experienced a pulmonary embolism or deep vein thrombosis or died while taking any level dose of Xeljanz or Xeljanz XR for rheumatoid arthritis, psoriatic arthritis, or ulcerative colitis, or within three days of the last dose, contact us. Our lawyers would be honored to help you.
We can give you the support you need. We have the resources to investigate your situation and get you the justice you deserve. You pay nothing unless we win your case.